ABU DHABI, United Arab Emirates, November 12, 2024--(BUSINESS WIRE)--The Advanced Technology Research Council’s ...
Inc Arabia on MSN15h
TII’s Dr. Chaouki Kasmi On Furthering AI Adoption In The UAE"Our objective is really to put artificial intelligence (AI) and generative AI in the core of our innovation processes, and to make sure that we leverage modern and cutting-edge models to innovate at ...
On Friday, AtriCure Inc (ATRC) stock saw a modest uptick, ending the day at $33.51 which represents a slight increase of $0.33 or 0.99% from the prior close of $33.18. The stock opened at $33.32 and ...
Inc Arabia on MSN3d
ATRC’s VentureOne Launches SteerAIThe commercialization arm of the UAE’s Advanced Technology Research Council's (ATRC), VentureOne, has launched SteerAI, a ...
The Advanced Technology Research Council’s (ATRC) commercialisation arm, VentureOne, has launched SteerAI, which offers an AI-driven mobility system that can transform standard industrial vehicles ...
SteerAI’s advanced software stack and hardware kit make industrial vehicles autonomous.• New venture, powered by VentureOne, the ATRC’s commercialization arm, will begin with ground vehicles and ...
AtriCure (NASDAQ:ATRC – Free Report) had its price objective upped by UBS Group from $35.00 to $40.00 in a research note released on Wednesday, Benzinga reports. The brokerage currently has a buy ...
On Wednesday, AtriCure Inc (ATRC) stock saw a modest uptick, ending the day at $34.83 which represents a slight increase of $5.40 or 18.35% from the prior close of $29.43. The stock opened at $34.4 ...
MASON, Ohio, November 07, 2024--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management ...
Good afternoon. And welcome to AtriCure's Third Quarter 2024 Earnings Conference Call. This call is being recorded for replay purposes. And at this time, all participants are in listen-only mode ...
AtriCure (NASDAQ:ATRC – Get Free Report) had its price objective hoisted by equities research analysts at Oppenheimer from $32.00 to $36.00 in a report issued on Wednesday, Benzinga reports. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback